The stock market snapped a five-week losing streak even as oil prices soared on President Trump's Iran war comments.

A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help reduce stroke risk.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boston Scientific, one of the top 100 medical device companies, reported positive clinical trial results over the weekend that could support FDA label expansion of its Watchman FLX device. Boston ...

NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) and a high stroke risk who were eligible for long-term anticoagulation, left atrial appendage occlusion (LAAO) was no worse than direct ...

Study suggests a path forward for device therapy, though caveats are plenty ...

Boston Scientific (BSX) stock tumbled 9% to two-year lows after Watchman trial data revealed stroke concerns and Raymond James downgraded the stock.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1134 ET – Raymond James downgrades Boston Scientific to ...

Memorial Health System is celebrating a major milestone Tuesday. Dr. Umair Malik has completed over 100 Watchman procedures, ...

In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...

A device which helps people with Motor Neuron Disease communicate with family members has been donated to the Isle of Man's Hospital. The Gridpad communication device provides text to speech output to ...